A One-Pill Answer to Treating H.I.V.

The first treatment for H.I.V. in the form of one pill taken once a day is going to market in the United States.  A spokesman for the drug company Bristol-Myers Squibb says the new product, called Atripla, has already been shipped to suppliers.